Human papillomavirus (HPV) is now established as the principal cause of an increase in
incidence of a subset of head and neck squamous cell cancers (HNCs) in numerous …

An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

Background Human papillomavirus vaccination and cervical screening are lacking in most
lower resource settings, where approximately 80% of more than 500 000 cancer cases …

Genotyping may improve risk stratification of high‐risk (HR) human papillomavirus (HPV)‐
positive women in cervical screening programs; however, prospective data comparing the …

Background HPV testing is replacing cytology for cervical cancer screening because of
greater sensitivity and superior reassurance following negative tests for the dozen HPV …

This chapter addresses the natural history of anogenital human papillomavirus (HPV)
infection. Cervical infections are the best understood HPV infection. Cervical HPV …

Simple Summary The microbiota can modulate immune responses and modify the
physiology of the human organism, thereby increasing infective risks and a neoplastic …

Background. Data on the relative carcinogenic potential of human papillomavirus (HPV)
types among women infected with human immunodeficiency virus (HIV)(WHIV) are needed …

Purpose: Cytology-based screening has limited sensitivity to detect prevalent cervical
precancers. Human papilloma virus (HPV) DNA testing is highly sensitive and provides a …

Methods Risk estimates were drawn from a subset of women in the Kaiser Permanente
Northern California screening program, whose residual cervical specimens were HPV typed …